Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Cardiology
Antiplatelets: summary of latest guidance
Antiplatelets: summary of latest guidance
The table below summarises the most recent guidelines regarding antiplatelets:| Diagnosis | 1st line | 2nd line |
|---|---|---|
| Acute coronary syndrome (medically treated) | Aspirin (lifelong) & ticagrelor (12 months) | If aspirin contraindicated, clopidogrel (lifelong) |
| Percutaneous coronary intervention | Aspirin (lifelong) & prasugrel or ticagrelor (12 months) | If aspirin contraindicated, clopidogrel (lifelong) |
| TIA | Clopidogrel (lifelong) | Aspirin (lifelong) & dipyridamole (lifelong) |
| Ischaemic stroke | Clopidogrel (lifelong) | Aspirin (lifelong) & dipyridamole (lifelong) |
| Peripheral arterial disease | Clopidogrel (lifelong) | Asprin (lifelong) |
+PassMedicine Notes
The table below summarises the most recent guidelines regarding antiplatelets:
Diagnosis_1st line_2nd line| Acute coronary syndrome (medically treated)_ Aspirin (lifelong) & ticagrelor (12 months)_ If aspirin contraindicated, clopidogrel (lifelong)| Percutaneous coronary intervention_Aspirin (lifelong) & prasugrel or ticagrelor (12 months)_ If aspirin contraindicated, clopidogrel (lifelong)| TIA _Clopidogrel (lifelong) _Aspirin (lifelong) & dipyridamole (lifelong)| Ischaemic stroke_ Clopidogrel (lifelong) _Aspirin (lifelong) & dipyridamole (lifelong)| Peripheral arterial disease_ Clopidogrel (lifelong)_ Asprin (lifelong)|